Asset icon - trade crypto, stocks, and gold on Pluang
Trade on Pluang
One platform for all markets
Download
Investment
Features
FeesSafety
Academy
More
Pluang+
Asset icon - trade crypto, stocks, and gold on Pluang

Buy & Sell Air Products & Chemicals, Inc. (APD) – Air Products & Chemicals, Inc. Price Today

24H
1W
1M
3M
YTD
1Y
5Y

Brain implants market to hit $18.39B by 2035, driven by advances in neurotechnology and rising neurological disorders.

The global brain implants market, valued at $7.10 billion in 2025, is projected to grow at a CAGR of 9.99% to reach $18.39 billion by 2035. Growth is fueled by advances in neurotechnology, including deep brain stimulation and brain-computer interface...

Market News
1 hour ago
Sns Insider
Bullish
news icon
pluang ai news

SpaceX secures data center deals worth $76B through 2029 with Anthropic, Google, and Reflection.

SpaceX has landed major data center contracts with Anthropic, Google, and Reflection, potentially generating over $76 billion in revenue through 2029. These deals highlight SpaceX's expanding role beyond space exploration into cloud infrastructure. T...

Market News
1 hour ago
Sean Williams
Bullish
news icon
pluang ai news

Genflow Biosciences to present promising SIRT6 gene therapy results in aged dogs at October summit

Genflow Biosciences will present data from its Age Dogs clinical trial on centenarian SIRT6 gene therapy at the Animal Longevity Summit in Toronto this October. The trial shows promise in treating sarcopenia and longevity in aged dogs, with potential...

Market News
4 hours ago
Proactive Investors
Bullish
news icon
pluang ai news

South Korea's KOSPI index swings wildly; Bitcoin drops to September 2024 lows amid market volatility.

South Korea's KOSPI index experienced extreme volatility this week, dropping 10% on Tuesday, then rebounding 3.3% and 5.4% on Wednesday and Thursday, before falling 5.8% on Friday. The U.S. Dollar Index reached a one-year high, while Bitcoin fell 5.3...

Market News
5 hours ago
Seeking Alpha
Bearish
news icon
pluang ai news

SELLAS Life Sciences nears key Phase 3 AML trial results with strong cash position and promising drug GPS.

SELLAS Life Sciences is advancing its acute myeloid leukemia (AML) treatment with its lead drug galinpepimut-S (GPS) approaching pivotal Phase 3 trial results in the REGAL study. The company also progresses another candidate, SLS009, targeting high-r...

Market News
5 hours ago
Seeking Alpha
Bullish
news icon
pluang ai news

Mitsubishi Electric posts strong revenue and profit growth despite restructuring costs.

Mitsubishi Electric Corporation reported solid revenue and operating profit growth driven by investments in electrification, semiconductors, datacenters, and defense. The life segment, including air conditioning and building systems, remains the larg...

Market News
6 hours ago
Seeking Alpha
Neutral
pluang ai news

Waton Financial launches MoTA Alpha, an AI-driven investment platform with a new agent marketplace and enhanced collaboration.

Waton Financial Limited has released MoTA Alpha, a major upgrade to its AI-powered investment platform that introduces an Agent Talents Market for third-party AI trading agents and improves multi-agent collaboration and user experience. This launch m...

Market News
6 hours ago
PRNewsWire
Bullish
news icon
pluang ai news

Solvonis reports positive data advancing alcohol use disorder treatment using esketamine.

Solvonis Therapeutics announced positive preclinical pharmacokinetic data for its SVN-002 program, repurposing Johnson & Johnson's esketamine to treat moderate to severe alcohol use disorder. The data showed comparable drug exposure via sublingual an...

Market News
6 hours ago
Proactive Investors - Finance
Bullish
news icon
pluang ai news

Solvonis reports positive data advancing alcohol use disorder drug to Phase 2b trial in the US.

Solvonis Therapeutics announced positive pharmacokinetic data for its SVN-002 program, repurposing J&J's esketamine for moderate to severe alcohol use disorder. The data show comparable drug exposure via sublingual and buccal delivery to the approved...

Market News
7 hours ago
Proactive Investors
Bullish
news icon
pluang ai news

SpaceX IPO sparks investor interest in Rocket Lab as the next big public space launch company.

SpaceX's 2026 IPO on Nasdaq under the ticker SPCX has established a public market benchmark for the space launch economy, prompting investors to seek other investable companies in the sector. Rocket Lab Corporation (Nasdaq: RKLB) stands out with reco...

Market News
10 hours ago
Usa News Group Market Commentary
Bullish
news icon
pluang ai news
Catch up fast with Aura AI
Get an AI-generated news summary for this asset in seconds.

Key Stats

  • Market Cap
    $62.34B
  • Sector
    Basic Materials
  • 3M Drawdown
    -9.7%
  • Enterprise Value
    $79.74B
  • Dividend Yield
    2.59%
  • Typical Hold Time
    58 days
$277.79
52W Low: $230.42
09 Dec 2025
52W High: $306.2
13 May 2026

Air Products & Chemicals, Inc. (APD) is currently valued at a market capitalization of $62.34B, with an enterprise value of $79.74B. Over the past 52 weeks, Air Products & Chemicals, Inc. has traded between a low of $230.42 and a high of $306.2, highlighting its annual price range. Over the past three months, Air Products & Chemicals, Inc. has recorded a drawdown of -9.7%, reflecting recent price volatility. Air Products & Chemicals, Inc. offers a dividend yield of 2.59%, with the most recent dividend of $1.81 paid on 01 Apr 26. On average, investors hold Air Products & Chemicals, Inc. for approximately 58 days, indicating typical investor behavior on the platform.

Let’s invest in this asset by signing up or download!